GAUSH MEDITECH (02407): The artificial intraocular lens implantation system has obtained the medical device registration certificate.

GAUSH MEDITECH (02407) announced that its wholly-owned subsidiary Gaoshitaijing Medical Technology Co., Ltd.'s "Artificial Intraocular Lens Implantation System" has been granted a Class II Medical Device Registration Certificate by the Guangdong Provincial Drug Administration. According to the "Chinese Adult Cataract Removal Surgery Guideline (2023)," cataract is the leading cause of blindness worldwide. With the aging population, the prevalence of cataracts is increasing every year. According to statistics from the Chinese Ophthalmological Society, the incidence of cataracts in the Chinese population aged 60 to 89 is 80%, and in those aged 90 and above, it is over 90%. It is estimated that by 2050, the adult cataract population in China will exceed 240 million. The current commonly used cataract treatment surgical methods all require the implantation of an artificial intraocular lens system to inject an artificial intraocular lens into the eye to replace the cloudy natural lens and restore the vision of cataract patients. According to the "Expert Consensus on High Myopia Prevention and Control (2023)," myopia is a highly prevalent disease worldwide, with a global myopia prevalence rate exceeding 28.3% and projected to reach 49.8% by 2050. The prevalence of high myopia is expected to increase from the current 4.0% to 9.8% by then. The "Myopia Prevention and Control Guidelines (2024)" show that myopia correction can be achieved through crystalline eye artificial intraocular lens implantation surgery, which also requires the implantation of an artificial intraocular lens system to inject the crystalline eye artificial intraocular lens into the eye to correct myopia. The artificial intraocular lens implantation system approved this time (Registration Certificate Number: Yue Xie Zhun 20242161490) designed by Gaoshitaijing independently can be used for both cataract surgery and myopia correction with crystalline eye artificial intraocular lens implantation surgery. This product can meet the needs of the group's single-focus and multi-focus artificial intraocular lenses and can also be selected by other lens manufacturers for compatibility.